Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity and may not reduce sleep disturbance or flare-ups, finds a review of the latest trial […]
Researchers have uncovered a previously unknown mechanism that helps aging cells drive the chronic inflammation linked to many age-related diseases. The findings reveal how dysfunctional mitochondria—the cell’s energy-producing structures—work with the cell’s epigenetic machinery to […]
A single IV injection of a microRNA-based biologic developed by Guangping Gao, Ph.D., Robert H. Brown Jr., DPhil, MD, Jun Xie, Ph.D., and Zuoshang Xu, MD, Ph.D., suppressed production of the mutant SOD1 protein that […]
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with alcohol use disorder (AUD).This article was […]
For patients with moderate-to-severe hidradenitis suppurativa (HS), povorcitinib (an oral Janus kinase 1 inhibitor) is beneficial, according to a study published online July 23 in Nature Medicine.This article was originally published on MedicalXpress.com
An unexpected observation by a University of Queensland researcher could lead to a new treatment for deadly infectious diseases including COVID‑19, pneumonia in infants and children, or viral infections caused by Ebola and hantavirus.This article […]
A new pan-European study has identified the key behavioral factors that influence whether health care professionals prescribe new, novel or nonroutine treatments for patients with neurodegenerative diseases.This article was originally published on MedicalXpress.com
GLP-1 medications such as Ozempic have transformed the treatment of type 2 diabetes, helping millions of patients better control their blood sugar while reducing cardiovascular risk and, for many, promoting substantial weight loss.This article was […]
Scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborators have uncovered a rare genetic mutation that enables some blood cancers to evade both approved Bruton tyrosine […]
A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life’s End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial. The findings […]
© 2025 SimplyWell.ca